Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Abscopal Effect of Frozen Autograft Reconstruction Combined with an Immune Checkpoint Inhibitor Analyzed Using a Metastatic Bone Tumor Model.

Tytuł:
Abscopal Effect of Frozen Autograft Reconstruction Combined with an Immune Checkpoint Inhibitor Analyzed Using a Metastatic Bone Tumor Model.
Autorzy:
Yonezawa N; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan.
Murakami H; Department of Orthopaedic Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467-8601, Japan.
Demura S; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan.
Kato S; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan.
Miwa S; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan.
Yoshioka K; Department of Orthopaedic Surgery, National Hospital Organization Kanazawa Medical Center, Kanazawa, Ishikawa 920-8650, Japan.
Shinmura K; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan.
Yokogawa N; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan.
Shimizu T; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan.
Oku N; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan.
Kitagawa R; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan.
Handa M; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan.
Annen R; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan.
Kurokawa Y; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan.
Fushimi K; Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Ishikawa 920-8641, Japan.
Mizukoshi E; Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Ishikawa 920-8641, Japan.
Tsuchiya H; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan.
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Feb 17; Vol. 22 (4). Date of Electronic Publication: 2021 Feb 17.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI, [2000-
MeSH Terms:
Autografts/*drug effects
Bone Neoplasms/*drug therapy
Bone Neoplasms/*pathology
Immune Checkpoint Inhibitors/*therapeutic use
Animals ; Bone Neoplasms/immunology ; CD8-Positive T-Lymphocytes/immunology ; Carcinogenesis/pathology ; Cell Proliferation/drug effects ; Disease Models, Animal ; Female ; Immune Checkpoint Inhibitors/pharmacology ; Mice, Inbred C3H ; Neoplasm Metastasis ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Programmed Cell Death 1 Receptor/metabolism ; Splenomegaly/pathology ; Tumor Burden/drug effects ; Mice
References:
Clin Cancer Res. 2006 Dec 15;12(24):7465-75. (PMID: 17189420)
J Bone Miner Res. 1998 Mar;13(3):400-8. (PMID: 9525340)
Immunology. 1968 Feb;14(2):149-58. (PMID: 4966655)
J Vasc Interv Radiol. 2019 Mar;30(3):466-469. (PMID: 30819495)
Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):728-34. (PMID: 15701862)
Eur Spine J. 2016 May;25 Suppl 1:53-7. (PMID: 26100278)
J Urol. 1997 Oct;158(4):1585-8. (PMID: 9302178)
Clin Exp Immunol. 2011 Feb;163(2):165-77. (PMID: 21087443)
Eur Spine J. 2019 Jun;28(Suppl 2):41-50. (PMID: 30465309)
Insights Imaging. 2019 May 20;10(1):53. (PMID: 31111237)
Sci Rep. 2016 Nov 18;6:36663. (PMID: 27857157)
PLoS One. 2013 May 29;8(5):e64818. (PMID: 23734222)
J Orthop Sci. 2003;8(3):374-80. (PMID: 12768481)
Int Immunol. 1998 Oct;10(10):1563-72. (PMID: 9796923)
Cryobiology. 2013 Aug;67(1):17-22. (PMID: 23619024)
Breast Cancer Res Treat. 2005 Mar;90(1):97-104. (PMID: 15770533)
Cancer Med. 2016 Sep;5(9):2469-76. (PMID: 27485505)
Cryobiology. 2001 Feb;42(1):59-68. (PMID: 11336490)
Bone. 1998 Jul;23(1):27-32. (PMID: 9662127)
Gan. 1982 Jun;73(3):462-9. (PMID: 7129011)
J Bone Joint Surg Br. 2008 Sep;90(9):1249-55. (PMID: 18757969)
Cryobiology. 2003 Jun;46(3):238-45. (PMID: 12818213)
Mater Sci Eng C Mater Biol Appl. 2020 Mar;108:110411. (PMID: 31923946)
Cryobiology. 2018 Jun;82:22-26. (PMID: 29680230)
PLoS One. 2017 Feb 21;12(2):e0171559. (PMID: 28222111)
Oncotarget. 2018 Jan 18;10(41):4180-4191. (PMID: 31289616)
Cryobiology. 2006 Dec;53(3):360-6. (PMID: 16973145)
Eur Spine J. 2014 May;23 Suppl 2:222-7. (PMID: 24097232)
J Clin Invest. 2014 Feb;124(2):687-95. (PMID: 24382348)
Clin Cancer Res. 2009 Sep 1;15(17):5379-88. (PMID: 19706802)
Front Oncol. 2018 Mar 28;8:85. (PMID: 29644213)
Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):655-66. (PMID: 16199306)
Cryobiology. 2001 Feb;42(1):49-58. (PMID: 11336489)
N Engl J Med. 2012 Mar 8;366(10):925-31. (PMID: 22397654)
Clin Cancer Res. 2008 Feb 15;14(4):1159-66. (PMID: 18281550)
Cancer Res. 2012 Jan 15;72(2):430-9. (PMID: 22108823)
Cryobiology. 2020 Dec;97:1-4. (PMID: 32097610)
Neoplasma. 2014;61(6):659-71. (PMID: 25341995)
Chin Clin Oncol. 2014 Sep;3(3):30. (PMID: 25841456)
Neurosurg Focus. 2015 Mar;38(3):E6. (PMID: 25727228)
Prostate Cancer Prostatic Dis. 2018 Apr;21(1):126-136. (PMID: 29556048)
Clin Exp Metastasis. 2007;24(3):191-200. (PMID: 17487560)
Acta Biomater. 2016 Feb;31:425-434. (PMID: 26675126)
Am Health Drug Benefits. 2015 Aug;8(Spec Issue):41. (PMID: 26380628)
Cancer Immunol Immunother. 2016 Aug;65(8):973-82. (PMID: 27312061)
Sci Transl Med. 2016 Mar 2;8(328):328rv4. (PMID: 26936508)
Clin Oral Implants Res. 2011 Apr;22(4):349-56. (PMID: 21561476)
PLoS One. 2018 Jan 25;13(1):e0191679. (PMID: 29370240)
J Cancer Res Clin Oncol. 1983;105(1):20-3. (PMID: 6833336)
Immunology. 1967 Apr;12(4):395-410. (PMID: 4960713)
J Bone Joint Surg Br. 2005 Feb;87(2):218-25. (PMID: 15736747)
mSphere. 2018 Aug 22;3(4):. (PMID: 30135222)
BJU Int. 2005 Jun;95(9):1187-91. (PMID: 15892798)
Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1306-10. (PMID: 22208977)
Cryobiology. 2009 Feb;58(1):1-11. (PMID: 19007768)
Antiviral Res. 2012 Jul;95(1):49-56. (PMID: 22609829)
Grant Information:
201820136 Uehara Memorial Foundation
Contributed Indexing:
Keywords: abscopal effect; frozen autograft; tumor; tumor-suppressive effect
Substance Nomenclature:
0 (Immune Checkpoint Inhibitors)
0 (Programmed Cell Death 1 Receptor)
Entry Date(s):
Date Created: 20210306 Date Completed: 20210413 Latest Revision: 20240226
Update Code:
20240226
PubMed Central ID:
PMC7922593
DOI:
10.3390/ijms22041973
PMID:
33671258
Czasopismo naukowe
We evaluated the abscopal effect of re-implantation of liquid nitrogen-treated tumor-bearing bone grafts and the synergistic effect of anti-PD-1 (programmed death-1) therapy using a bone metastasis model, created by injecting MMT-060562 cells into the bilateral tibiae of 6-8-week-old female C3H mice. After 2 weeks, the lateral tumors were treated by excision, cryotreatment using liquid nitrogen, excision with anti-PD-1 treatment, and cryotreatment with anti-PD-1 treatment. Anti-mouse PD-1 4H2 was injected on days 1, 6, 12, and 18 post-treatment. The mice were euthanized after 3 weeks; the abscopal effect was evaluated by focusing on growth inhibition of the abscopal tumor. The re-implantation of frozen autografts significantly inhibited the growth of the remaining abscopal tumors. However, a more potent abscopal effect was observed in the anti-PD-1 antibody group. The number of CD8+ T cells infiltrating the abscopal tumor and tumor-specific interferon-γ (IFN-γ)-producing spleen cells increased in the liquid nitrogen-treated group compared with those in the excision group, with no significant difference. The number was significantly higher in the anti-PD-1 antibody-treated group than in the non-treated group. Overall, re-implantation of tumor-bearing frozen autograft has an abscopal effect on abscopal tumor growth, although re-implantation of liquid nitrogen-treated bone grafts did not induce a strong T-cell response or tumor-suppressive effect.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies